PXD056703 is an
original dataset announced via ProteomeXchange.
Dataset Summary
| Title | Identification of a Potent Tau-Aggregate Clearing Compound Using Chemoproteomic-Integrated Phenotypic Screening (Enrichment) |
| Description | Tauopathies are characterized by the formation of tau protein-based neurofibrillary tangles which impede neuronal function and contribute to the pathology of highly prevalent neurodegenerative disorders such as Alzheimer’s and Pick’s diseases. Despite the impact of these diseases, the underlying biology is poorly understood. Current therapeutic efforts to reduce and remove tau aggregates target a variety of cellular mechanisms including altering tau phosphorylation through kinase inhibition, stimulating autophagy and upregulating protein quality control mechanisms such as the endoplasmic reticulum associated protein degradation pathway (ERAD), however these efforts have not thus far resulted in effective therapeutic interventions. Here, we sought to identify new targets and mechanisms that might be exploited to address tauopathies, through a chemoproteomic-integrated phenotypic screen using a cellular model of tau-aggregate clearance. An optimized analogue derived from this effort induced tau aggregate clearance in both SH-SY5Y and iPSC-derived human neuron models of hTauP301L aggregation at nanomolar concentrations and led to the activation of the ERAD pathway. Chemoproteomic studies revealed interactions with several resident endoplasmic reticulum proteins containing thioredoxin domains whose activities are involved in the ERAD pathway and protein quality control. Genetic knockdown of one of these targets, protein disulfide isomerase 1 (P4HB), was found to recapitulate the tau aggregate-clearance phenotype, indicating that modulation of this protein may be of therapeutic benefit for tauopathies. |
| HostingRepository | PRIDE |
| AnnounceDate | 2025-09-05 |
| AnnouncementXML | Submission_2025-09-04_16:30:09.765.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Louis Conway |
| SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
| ModificationList | TMT6plex-126 reporter+balance reagent acylated residue |
| Instrument | Orbitrap Fusion Lumos |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
| 0 | 2024-10-10 15:52:52 | ID requested | |
| ⏵ 1 | 2025-09-04 16:30:10 | announced | |
Publication List
| Dataset with its publication pending |
Keyword List
| submitter keyword: fragment,tauopathy, screening, chemoproteomics, photoactivation |
Contact List
| Christopher G Parker |
| contact affiliation | Professor, Department of Chemistry, The Scripps Research Institute |
| contact email | cparker@scripps.edu |
| lab head | |
| Louis Conway |
| contact affiliation | Scripps Research |
| contact email | lconway@scripps.edu |
| dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/09/PXD056703 |
| PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD056703
- Label: PRIDE project
- Name: Identification of a Potent Tau-Aggregate Clearing Compound Using Chemoproteomic-Integrated Phenotypic Screening (Enrichment)